Accelerated activation of the coagulation pathway during cardiopulmonary bypass in aortic replacement surgery: a prospective observational study

[1]  A. Usui,et al.  Fibrinogen concentrate administration attributes to significant reductions of blood loss and transfusion requirements in thoracic aneurysm repair , 2014, Journal of Cardiothoracic Surgery.

[2]  T. Ohmori,et al.  Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study , 2014, Critical Care.

[3]  G. Broze,et al.  Tissue factor pathway inhibitor: structure-function. , 2012, Frontiers in bioscience.

[4]  A. Haverich,et al.  Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study , 2009, British journal of anaesthesia.

[5]  D. D. de Jong,et al.  Thrombin generation during cardiopulmonary bypass: the possible role of retransfusion of blood aspirated from the surgical field , 2003, Thrombosis journal.

[6]  W. Chandler,et al.  Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. , 2003, Blood.

[7]  R. Hetzer,et al.  Hemostatic Activation and Inflammatory Response during Cardiopulmonary Bypass: Impact of Heparin Management , 2002, Anesthesiology.

[8]  J. Arnout,et al.  Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. , 2002, The Journal of thoracic and cardiovascular surgery.

[9]  C. Triggs,et al.  Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. , 2002, The Journal of thoracic and cardiovascular surgery.

[10]  D. Loskutoff,et al.  Regulation of tissue factor gene expression in obesity. , 2001, Blood.

[11]  O. Kemmotsu,et al.  Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor. , 2001, Journal of cardiothoracic and vascular anesthesia.

[12]  J. Pepper,et al.  Tissue Factor Is Rapidly Elevated in Plasma Collected from the Pericardial Cavity during Cardiopulmonary Bypass , 2000, Thrombosis and Haemostasis.

[13]  M. Underwood,et al.  On-pump versus off-pump coronary revascularization: evaluation of renal function. , 1999, The Annals of thoracic surgery.

[14]  G. Despotis,et al.  Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update. , 1999, Journal of cardiothoracic and vascular anesthesia.

[15]  R. Shemin,et al.  Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. , 1998, The Annals of thoracic surgery.

[16]  B Barzilai,et al.  Adverse cerebral outcomes after coronary bypass surgery. , 1997, The New England journal of medicine.

[17]  E. Spitznagel,et al.  More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACT , 1996, Thrombosis and Haemostasis.

[18]  D. Loskutoff,et al.  Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. , 1996, The Journal of clinical investigation.

[19]  E. Spitznagel,et al.  The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. , 1995, The Journal of thoracic and cardiovascular surgery.

[20]  C. Greenberg,et al.  Characterization of Prothrombin Activation during Cardiac Surgery by Hemostatic Molecular Markers , 1994, Anesthesiology.

[21]  H. Philippou,et al.  Thrombin Production, Inactivation and Expression during Open Heart Surgery Measured by Assays for Activation Fragments Including a New ELISA for Prothrombin Fragment F1+2 , 1993, Thrombosis and Haemostasis.

[22]  S. Brister,et al.  Thrombin Generation during Cardiac Surgery: Is Heparin the Ideal Anticoagulant? , 1993, Thrombosis and Haemostasis.

[23]  H. Philippou,et al.  Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. , 1993, Blood.